Numinus Wellness (Numinus Wellness) LT-Debt-to-Total-Asset : 0.25 (As of Feb. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Numinus Wellness LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Numinus Wellness's long-term debt to total assests ratio for the quarter that ended in Feb. 2024 was 0.25.

Numinus Wellness's long-term debt to total assets ratio increased from Feb. 2023 (0.16) to Feb. 2024 (0.25). It may suggest that Numinus Wellness is progressively becoming more dependent on debt to grow their business.

Numinus Wellness LT-Debt-to-Total-Asset Historical Data

The historical data trend for Numinus Wellness's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Numinus Wellness LT-Debt-to-Total-Asset Chart

Numinus Wellness Annual Data

Trend

Aug19

Aug20

Aug21

Aug22

Aug23

LT-Debt-to-Total-Asset

0.03

0.06

0.02

0.12

0.23

Numinus Wellness Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.16	0.19	0.23	0.27	0.25

Numinus Wellness LT-Debt-to-Total-Asset Calculation

Numinus Wellness's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Aug. 2023 is calculated as

LT Debt to Total Assets (A: Aug. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Aug. 2023 )	/	Total Assets (A: Aug. 2023 )
	=	4.186	/	18.053
	=	0.23

Numinus Wellness's Long-Term Debt to Total Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

LT Debt to Total Assets (Q: Feb. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Feb. 2024 )	/	Total Assets (Q: Feb. 2024 )
	=	3.596	/	14.281
	=	0.25

Numinus Wellness (OTCPK:NMNWF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Numinus Wellness LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Numinus Wellness's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Numinus Wellness (Numinus Wellness) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Numinus Wellness Inc (OTCPK:NMNWF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

NUMIF:USA LR23:Germany NUMI:Canada

Address

801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4

Website

https://www.numinus.ca

Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.